We are live on ! Find out more
VCIM

Velan Capital Investment Management Portfolio holdings

AUM $160M
1-Year Est. Return 517.12%
This Fund
S&P 500
This Quarter Est. Return
+4.53%
1 Year Est. Return
+517.12%
3 Year Est. Return
+2,524.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$101M
AUM Growth
+$2.24M
Cap. Flow
+$4.08M
Cap. Flow %
4.04%
Top 10 Hldgs %
84.92%
Holding
31
New
7
Increased
6
Reduced
4
Closed
7

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$4.6M
2
HCSG icon
Healthcare Services Group
HCSG
+$3.35M
3
QIPT
Quipt Home Medical
QIPT
+$2.49M
4
TELA icon
TELA Bio
TELA
+$2.06M
5
ZYME icon
Zymeworks
ZYME
+$1.42M

Top Sells

Rank Stock Value
1
RDUS
Radius Health, Inc.
RDUS
+$18.4M
2
LNTH icon
Lantheus
LNTH
+$5.2M
3
ADMA icon
ADMA Biologics
ADMA
+$1.93M
4
CRBU icon
Caribou Biosciences
CRBU
+$1.14M
5
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
+$441K

Sector Composition

Rank Sector Weight
1 Healthcare 83.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FEZ icon
1
PUT
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.54B
$15.4M 15.26%
+500,000
New +$17.2M
LNTH icon
2
Lantheus
LNTH
$6.59B
$14.1M 13.95%
200,000
-68,658
-26% -$5.2M
IMCR icon
3
Immunocore
IMCR
$1.73B
$13.8M 13.66%
293,385
– –
ADMA icon
4
ADMA Biologics
ADMA
$2.18B
$12.8M 12.7%
5,269,155
-804,443
-13% -$1.93M
OPTN
5
DELISTED
OptiNose
OPTN
$7.97M 7.9%
145,105
+11,772
+9% +$646K
TELA icon
6
TELA Bio
TELA
$41.6M
$6.36M 6.31%
746,087
+247,849
+50% +$2.06M
HCSG icon
7
Healthcare Services Group
HCSG
$1.5B
$4.84M 4.8%
400,000
+227,000
+131% +$3.35M
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.26M 4.23%
68,829
+65,862
+2,220% +$4.6M
QIPT
9
DELISTED
Quipt Home Medical
QIPT
$3.34M 3.31%
800,000
+497,900
+165% +$2.49M
BCRX icon
10
BioCryst Pharmaceuticals
BCRX
$2.51B
$2.83M 2.81%
225,000
– –
STLN
11
Starling Oncology, Inc. Common Stock
STLN
$616M
$2.54M 2.52%
548,841
-51,159
-9% -$301K
JSPR icon
12
Jasper Therapeutics
JSPR
$26.6M
$2.24M 2.22%
321,904
– –
ZYME icon
13
Zymeworks
ZYME
$1.71B
$1.45M 1.43%
+234,902
New +$1.42M
SNDA icon
14
Sonida Senior Living
SNDA
$1.99B
$1.34M 1.33%
82,832
– –
ALIM
15
DELISTED
Alimera Sciences
ALIM
$1.16M 1.15%
227,602
+40,601
+22% +$247K
RZLT icon
16
Rezolute
RZLT
$451M
$1.1M 1.09%
400,000
– –
BLU
17
DELISTED
BELLUS Health Inc.
BLU
$1.06M 1.05%
+100,000
New +$1.06M
CFMS
18
DELISTED
Conformis, Inc. Common Stock
CFMS
$986K 0.98%
206,256
– –
XENE icon
19
Xenon Pharmaceuticals
XENE
$6.21B
$722K 0.72%
20,000
– –
COLL icon
20
Collegium Pharmaceutical
COLL
$882M
$640K 0.63%
+39,957
New +$705K
LMDX
21
DELISTED
LumiraDx Limited Common Shares
LMDX
$583K 0.58%
+571,428
New +$948K
ASRT
22
DELISTED
Assertio
ASRT
$533K 0.53%
+15,651
New +$708K
NYXH
23
Nyxoah
NYXH
$158M
$498K 0.49%
79,021
-11,976
-13% -$103K
GKOS icon
24
Glaukos
GKOS
$10.7B
$367K 0.36%
+6,896
New +$356K
CRBU icon
25
Caribou Biosciences
CRBU
$165M
– –
-210,695
Closed -$1.14M
1
2

Similar funds

BFAG
Blackston Financial Advisory Group The Villages, Florida $160M AUM 16.38% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM
SMF
Sterling Manor Financial Saratoga Springs, New York $160M AUM 13.84% 1-Year Est. Return
LCA
Legend Capital Advisors New York $160M AUM
SA
swisspartners Advisors Zurich, Switzerland $159M AUM 36.51% 1-Year Est. Return
SGCM
Sanchez Gaunt Capital Management Reno, Nevada $160M AUM
RP
RIHO Partners Tucson, Arizona $159M AUM
PCC
Perry Creek Capital New York $160M AUM 3.05% 1-Year Est. Return

Velan Capital Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, Velan Capital Investment Management held 31 positions worth $101M, up 2.3% from $98.6M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Velan Capital Investment Management deployed $4.08M of net new capital in Q3 2022, opening 7 new positions and adding to 6 existing holdings. Its largest new stake was Zymeworks: 234,902 shares worth $1.45M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 75% a quarter earlier.

On the sell side, the largest reduction was Lantheus, an estimated $5.2M trimmed.

  • Velan Capital Investment Management's largest Q3 2022 buy was Zymeworks: 234,902 shares worth $1.45M.
  • Velan Capital Investment Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022, an estimated $4.6M increase.
  • Velan Capital Investment Management's biggest Q3 2022 reduction was Lantheus, cutting an estimated $5.2M.
  • Velan Capital Investment Management fully exited Radius Health, Inc. in Q3 2022, selling an estimated $18.4M.
  • Velan Capital Investment Management's ten largest holdings make up 85% of its $101M portfolio in Q3 2022.
  • Velan Capital Investment Management opened 7 new positions and closed 7 in Q3 2022.
  • Velan Capital Investment Management's portfolio value rose 2.3% quarter-over-quarter to $101M.

Based on Velan Capital Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.